Investment Thesis
Linc invests in companies that create value and improve quality of life within Life Science, focusing on product-oriented businesses in the Nordic region. Their pharmaceutical investments are typically in early stages, while medical technology investments target more developed companies.
Stage Focus
Early-stage for pharmaceuticals, more mature for medical technology
Preferred startup development maturity for initial funding deployment.
Sectors & Themes
Product-oriented companies in the Nordic Life Science industry, primarily pharmaceutical and medical device companies
Core thematic spaces, technologies, and target market segments of interest.
Check Size Range
N/A
Standard financial allocation per investment round.
Outreach & Dossier Intelligence
Direct Verification Contact Email Pattern
Thesis Dossier Analysis Scorecard
Our agent analyzer scanned portfolio holdings and verified absolute match parameters...